XML 19 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statement of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock [Member]
Capital in Excess of Par Value [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Loss [Member]
Noncontrolling Interests [Member]
Beginning balance at Dec. 31, 2019 $ 5,215.5 $ 188.1 $ 3,825.7 $ 1,901.3 $ (759.6) $ 60.0
Beginning balance (in shares) at Dec. 31, 2019   188.1        
Net earnings 355.4     346.3   9.1
Net purchase of subsidiary shares from noncontrolling interests (10.8)         (10.8)
Dividends paid to noncontrolling interests (18.9)         (18.9)
Net change in pension asset/liability, net of taxes 1.2       1.2  
Foreign currency translation (380.1)       (381.3) 1.2
Change in fair value of derivative instruments, net of taxes (91.4)       (91.4)  
Compensation expense related to stock option plan grants 3.4   3.4      
Common stock issued in: purchase transactions 73.1 $ 0.7 72.4      
Common stock issued in: purchase transactions (in shares)   0.7        
Stock option plans 17.9 $ 0.4 17.5      
Stock option plans (in shares)   0.4        
Employee stock purchase plan 6.0 $ 0.1 5.9      
Employee stock purchase plan (in shares)   0.1        
Deferred compensation and restricted stock 15.0 $ (0.3) 15.3      
Deferred compensation and restricted (in shares)   0.3        
Cash dividends declared on common stock (86.2)     (86.2)    
Ending balance at Mar. 31, 2020 5,070.1 $ 189.6 3,909.6 2,161.4 (1,231.1) 40.6
Ending balance, (in shares) at Mar. 31, 2020   189.6        
Beginning balance at Dec. 31, 2020 $ 6,232.7 $ 193.7 4,264.4 2,371.7 (643.6) 46.5
Beginning balance (in shares) at Dec. 31, 2020 193.7 193.7        
Net earnings $ 393.7     382.1   11.6
Dividends paid to noncontrolling interests (10.3)         (10.3)
Net change in pension asset/liability, net of taxes 1.0       1.0  
Foreign currency translation 58.6       58.0 0.6
Change in fair value of derivative instruments, net of taxes 56.8       56.8  
Compensation expense related to stock option plan grants 3.7   3.7      
Common stock issued in: purchase transactions 67.5 $ 0.6 66.9      
Common stock issued in: purchase transactions (in shares)   0.6        
Stock option plans $ 30.2 $ 0.6 29.6      
Stock option plans (in shares) 0.7 0.6        
Employee stock purchase plan $ 7.0 $ 0.1 6.9      
Employee stock purchase plan (in shares)   0.1        
Shares issued to benefit plans 71.4 $ 0.6 70.8      
Shares issued to benefit plans (in shares)   0.6        
Deferred compensation and restricted stock 37.9 $ (0.3) 38.2      
Deferred compensation and restricted (in shares)   0.3        
Cash dividends declared on common stock (94.9)     (94.9)    
Ending balance at Mar. 31, 2021 $ 6,779.5 $ 195.9 $ 4,404.1 $ 2,658.9 $ (527.8) $ 48.4
Ending balance, (in shares) at Mar. 31, 2021 195.9 195.9